ARTICLE | Company News
Galen deal
May 3, 2004 7:00 AM UTC
GAL sold its U.K.-based pharmaceutical products sales and marketing business for £40 million ($72 million) in cash to a company held by GALN founder and former chairman Allen McClay. The business - which sells a range of products, including the analgesic Kapake, incontinence drug Regurin and oral contraceptive Loestrin - had revenues of $32.9 million in 2003 and $31.1 million in 2002. ...